EXPLORING THE ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE FLARE-UPS
Inflammatory Bowel Diseases · 28.02.2025 · 31 (Supplement_1) · S30-S30
DOI: 10.1093/ibd/izae282.066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 28.02.2025. Verfasst von Noor Albusta und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
INTRODUCTION Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a chronic condition marked by periods of remission and flare-ups. Antibiotics are often used in the treatment of infections in IBD patients, but growing evidence suggests that antibiotics may disrupt the gut microbiome, potentially triggering flare-ups. This study aims to investigate the association between antibiotic exposure and IBD flare-ups. METHODS A case-control study was conducted using medical records from 512 adult IBD patients (217 with Crohn’s disease and 295 with ulcerative colitis) treated at Bahrain Government Hospitals between June 2022 and June 2024. Cases (n = 255) were IBD patients who experienced a disease flare-up during the study period, while controls (n = 257) were IBD patients who remained in clinical remission. Antibiotic exposure was defined as any prescription for antibiotics within three months prior to the flare-up (for cases) or within the matched time frame for controls. Antibiotic use was classified into broad-spectrum and narrow-spectrum categories. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression to evaluate the association between antibiotic exposure and disease flare-ups, adjusting for potential confounders, including age, gender, smoking status, medication use, and prior disease activity. RESULTS Among the 255 cases, 148 (58.04%) had been exposed to antibiotics in the three months preceding the flare-up, compared to 92 (35.80%) in the control group (p < 0.01). Antibiotic exposure was associated with significantly higher odds of flare-ups, with an adjusted odds ratio (OR) of 2.35 (95% CI, 1.70–3.25). The association was more prominent in patients with Crohn’s disease (OR = 2.75, 95% CI, 1.90–4.00) compared to those with ulcerative colitis (OR = 2.00, 95% CI, 1.40–2.85). Furthermore, broad-spectrum antibiotics were associated with greater odds of flare-ups (OR = 3.10, 95% CI, 2.15–4.45) compared to narrow-spectrum antibiotics (OR = 1.85, 95% CI, 1.25–2.65). CONCLUSION This study highlights a significant association between antibiotic exposure and disease flare-ups in IBD patients, particularly in those with Crohn’s disease and those using broad-spectrum antibiotics. While these findings suggest that antibiotics may play a role in triggering disease activity, more studies are needed to better understand the relationship between antibiotic use and IBD flare-ups. Additionally, exploring the mechanisms by which antibiotics impact the gut microbiota and immune response in IBD could provide crucial insights for more personalized treatment approaches aimed at minimizing flare-up risks.
Zitieren
APA
Albusta, N., Kheyami, A., & Hasan, M. (2025). EXPLORING THE ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE FLARE-UPS. Inflammatory Bowel Diseases, 31(Supplement_1), S30-S30. https://doi.org/10.1093/ibd/izae282.066
Vancouver
Albusta N, Kheyami A, Hasan M. EXPLORING THE ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE FLARE-UPS. Inflammatory Bowel Diseases. 2025;31(Supplement_1):S30-S30. doi:10.1093/ibd/izae282.066
BibTeX
@article{Albusta2025,
author = {Albusta, Noor and Kheyami, Ammar and Hasan, Mohamed},
title = {EXPLORING THE ASSOCIATION BETWEEN ANTIBIOTIC USE AND INFLAMMATORY BOWEL DISEASE FLARE-UPS},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {Supplement_1},
pages = {S30--S30},
doi = {10.1093/ibd/izae282.066}
}
EUVIMED